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Abstract. Examining the epidemiology of stone disease can provide insight into etiology. There 
is a growing body of evidence that stone disease is not simply a disorder of the kidney. In fact, 
nephrolithiasis is clearly a systemic disorder. Conditions associated with stone disease include 
the classic ones such as inflammatory bowel disease and primary hyperparathyroidism. More 
recent studies have demonstrated strong associations with obesity, gout, diabetes and 
hypertension. Future studies will help uncover the underlying common pathophysiologic 
abnormalities. 
Key words: nephrolithiasis, obesity, diabetes, gout, hypertension, urine composition 
PACS: 87.19.Xx 
INTRODUCTION 
Epidemiology is defined as the study of the distribution and determinants of 
disease. Examination of these factors may provide insight into the systemic nature of 
nephrolithiasis. 
The distribution of nephrolithiasis is usually quantified in terms of prevalence and 
incidence. In the US, the prevalence of a history of stone disease increased from 3.8% 
in NHANES II (1976-80) to 5.2% in NHANES III (1988-1994) [1]. Somewhat 
surprisingly, a recent study from the Olmstead County Epidemiology Project reported 
that incidence rates appear to have stabilized or may have fallen over the past two 
decades [2]. 
Dietary risk factors 
Risk factors for stone disease are usually divided into three main categories: 
dietary, non-dietary and urinary. It is important to note that the importance of different 
risk factors varies by age and sex (and likely race). 
Dietary factors that have been consistently shown to reduce the risk of stone 
formation include higher dietary calcium intake and higher fluid intake [3-5]. In older 
men and women, higher potassium intake is also associated with reduced risk of stone 
formation. In women, but not in men, higher phytate intake reduces the risk. Sucrose 
intake is associated with an increased risk of stone formation. In older men, higher 
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vitamin C intake increases the risk. Other factors such as animal protein and 
magnesium have not been consistently associated with risk. 
Individual beverages may impact risk independent of their effect on urine volume 
[6, 7]. Beverages that have been associated with a reduced risk of stone formation 
include milk, coffee, tea, beer and wine, likely by increasing urine flow and reducing 
urine concentration. Grapefruit juice appears to increase the risk but the mechanism is 
unknown. 
Non-dietary risk factors 
A number of systemic conditions have been known to increase the risk of stone 
formation including inflammatory bowel disease and primary hyperparathyroidism. 
However, only recently has it been appreciated that more common systemic disorders 
influence the risk of nephrolithiasis. These conditions include obesity [8], gout [9, 10], 
and diabetes [11]. 
Obesity 
While obesity has long been believed to be associated with stone formation, 
evidence was lacking until recently. Taylor and colleagues [8] found in a prospective 
study of three large cohorts (Nurses' Health Study I, Nurses' Health Study II and the 
Health Professionals Follow-up Study) that the risk of stone formation increased with 
increasing weight (Fig. 1); the magnitude of the increase was greater in women than in 
men. 
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Figure 1. Relative risk of symptomatic kidney stones versus body mass index [8]. HPFS: Health 
Professionals Follow-up Study. NHS: Nurses' Health Study. 
Similar relations were seen when examining other measures of body size such as 
weight and waist circumference. These associations were independent of age, fluid 
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intake and other dietary risk factors. Thus, it appears that being overweight or obese 
increases the risk of stone formation independent of dietary factors. 
Gout 
Gout has long been associated with risk of uric acid stones but may also increase 
the risk of calcium oxalate stones. Using data from NHANES III, gout was associated 
with a 46% increased risk of being a stone former in men and 65% increased risk in 
women [10]. In the one prospective study, men with a history of gout were more than 
twice as likely as those with no history of gout to subsequently develop a kidney stone, 
independent of age, dietary factors and body mass index [9]. 
Diabetes mellitus 
Insulin resistance may be one potential explanation for the increased risk of stone 
formation observed with increasing BMI. The exact roles of insulin and insulin 
resistance in stone formation remain unclear. The association between a history of type 
II diabetes mellitus and risk of nephrolithiasis has only recently been studied. In cross-
sectional analyses, men and women with a history of diabetes were more likely to also 
have a history of nephrolithiasis [11]. When examined prospectively, the risk was 
increased by 58% in younger women and 27% in older women; there was no 
association in men but this may have been due to the late mean age of onset of 
diabetes in the male cohort. 
Hypertension 
A history of nephrolithiasis increases the risk of subsequently developing 
hypertension [12, 13]. However, a history of hypertension does not appear to increase 
the risk of stone formation. One possible explanation is that hypertension is more 
likely to develop as a result of renal damage related the obstruction or treatment of 
stone disease (e.g. ESWL). 
Urinary risk factors 
Examination of 24-hour urine results may provide insight into the potential 
mechanisms that will explain the associations between systemic disorders and 
nephrolithiasis. To date, two large studies have examined the relation between body 
size and 24-hour urine composition [14, 15]. Maalouf and colleagues reported an 
inverse association between urine pH and body weight [15]. Taylor and colleagues 
reported on all the commonly measured urinary factors [16]. In addition to confirming 
the inverse association with urine pH, an inverse association was observed for urinary 
calcium in women. Positive associations were seen for urine oxalate and citrate in 
women, but not men, and urine uric acid. There was no association with total volume. 
The relation between 24-hour urine composition and risk of hypertension has also 
been studied [17]. Surprisingly, there was no consistent association in a cross-sectional 
study between history of hypertension and urine excretion of calcium, magnesium, 
90 
sodium and potassium. However, urine citrate was strongly inversely associated with 
hypertension. The role of acid-base regulation in the etiology of hypertension deserves 
further study. 
CONCLUSIONS 
Nephrolithiasis is clearly a systemic disorder and a variety of factors influence urine 
composition of lithogenic substances, including the generation of acid and oxalate. 
Well accepted dietary risk factors, such as dietary calcium, are influenced by age, sex 
and body mass index. Future studies need to examine how these systemic factors 
interrelate and should result in improved preventive strategies that can be tailored to 
the individual patient. 
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